Randomized Controlled Trial of a Novel Communication Device Assessed During Noninvasive Ventilation Therapy

Area of Science:

• Respiratory Medicine
• Biomedical Engineering
• Clinical Trials

Background:

• Noninvasive ventilation (NIV) using positive airway pressure (PAP) is standard for acute respiratory failure (ARF).
• Communication impairment during NIV hinders patient care, increases distress, and may lead to higher intubation rates.
• Oronasal masks used in PAP therapy can significantly impede speech intelligibility.

Purpose of the Study:

• To quantify communication impairment experienced by patients undergoing continuous positive airway pressure (CPAP) therapy.
• To evaluate the effectiveness of a novel PAP communication device in improving speech intelligibility and comfort.
• To assess the impact of the communication device on patient-provider and patient-caregiver interactions.

Main Methods:

• A single-center randomized controlled trial involving 36 outpatients with OSA undergoing CPAP therapy.
• Communication intelligibility was measured by the percentage of correctly transcribed words and sentences during three assessment stages: baseline, mask-on baseline, and randomized device use (intervention or sham).
• Patient and partner Likert surveys assessed perceived intelligibility and comfort after each assessment stage.

Main Results:

• PAP therapy significantly reduced word and sentence intelligibility by 52% and 57%, respectively, compared to baseline.
• The communication device intervention arm showed significant improvements: word intelligibility increased by 75% and sentence intelligibility by 126% compared to the control arm.
• The device significantly enhanced perceived comfort for both outpatients (233% increase) and partners (245% increase).

Conclusions:

• A dedicated PAP communication device effectively mitigates speech intelligibility deficits caused by NIV/PAP therapy.
• The device significantly improves both objective communication measures and subjective comfort levels for patients and their partners.
• This study provides crucial quantitative data on communication challenges during PAP therapy and demonstrates a viable solution.